Deepbridge’s Start-Ups in Focus: FluoretiQ

by | Dec 17, 2021

Share this article

GBI Magazine spoke to Neciah Dorh, CEO of FluoretiQ, to talk about his Start-Up journey, and how the Deepbridge Life Sciences EIS scheme influenced it.

This is the fourth and final part of our series with Deepbridge, looking at the Start-Ups empowered by the Deepbridge Life Sciences EIS. Founded in 2010, Chester-based Deepbridge launched its first EIS fund in the 2013/14 tax year and specialises in providing venture capital to early-stage technology, life sciences and renewable energy companies.

FluoretiQ is an exemplar of the sort of Start-Up Deepbridge invest in with the Deepbridge Life Sciences EIS. FluoretiQ provides Rapid Bacterial Identification for Faster Treatment. In this interview Neciah helps detail the science behind his company, explaining how FluoretiQ have carried out so much scientific testing with such a small team.

If you would like to invest in FluoretiQ, or find out more about the companies invested in by the Deepbrige Life Sciences EIS, please see their website here.

 

Share this article

Related articles

GBI 35 | Opportunity Knocks in 2023 | December 2022

GBI 35 | Opportunity Knocks in 2023 | December 2022

Season’s Greetings to all our Readers and Clients. While some business sectors start to wind things down for the year, we are busier than ever planning for the Spring and the tax year end. So, with this in mind we bring you our usual mix of news and opportunities that...

Trending articles

IFA Talk logo

IFA Talk is our flagship podcast, designed to fit perfectly into your busy life, bringing the latest insight, analysis, news and interviews to you, wherever you are.

IFA Talk Podcast - listen to the latest episode